![Richard Brudnick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Brudnick
Directeur/Membre du Conseil chez
INFLARX N.V.
Fortune : 1 M $ au 31/05/2026
Profil
Richard H.
Brudnick currently works at InflaRx NV, as Independent Non-Executive Director from 2019, Scholar Rock Holding Corp., as Independent Director from 2023, Volition America, Inc., as Independent Director from 2021, Israel Biotech Fund, as Venture Advisor from 2018, and Prime Medicine, Inc., as Chief Business Officer from 2022.
Mr. Brudnick also formerly worked at James Brudnick Co., Inc., as President & Chief Executive Officer from 1984 to 1998, VolitionRX Ltd., as Independent Director from 2021 to 2023, Tamarix Pharma Ltd, as Director, Biogen, Inc., as Senior VP-Corporate Development & Strategy from 2014 to 2016, Codiak BioSciences, Inc., as Chief Business Officer & Head-Strategy from 2018 to 2022, and Bioverativ, Inc., as Executive Vice President-Business Development from 2016 to 2018.
Mr. Brudnick received his undergraduate degree in 1978 from Massachusetts Institute of Technology, Masters Business Admin degree in 1980 from MIT Sloan School of Management, and undergraduate degree and graduate degree from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 21 896 ( 0,02 % ) | 1 M $ | 31/05/2026 | |
INFLARX N.V. 0,03 % | 18/03/2026 | 50 000 ( 0,03 % ) | 120 000 $ | 31/05/2026 |
PRIME MEDICINE, INC. 0,01 % | 20/05/2025 | 20 000 ( 0,01 % ) | 71 000 $ | 31/05/2026 |
Postes actifs de Richard Brudnick
| Sociétés | Poste | Début |
|---|---|---|
| INFLARX N.V. | Directeur/Membre du Conseil | 14/02/2019 |
| PRIME MEDICINE, INC. | Corporate Officer/Principal | 01/07/2022 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur/Membre du Conseil | 06/04/2023 |
Volition America, Inc.
 Volition America, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic services | Directeur/Membre du Conseil | 25/03/2021 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 01/01/2018 |
Anciens postes connus de Richard Brudnick
| Sociétés | Poste | Fin |
|---|---|---|
| VOLITIONRX LIMITED | Directeur/Membre du Conseil | 23/06/2023 |
| CODIAK BIOSCIENCES | Corporate Officer/Principal | 01/07/2022 |
| BIOVERATIV INC | Corporate Officer/Principal | 01/03/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2016 |
| ░░░░░ ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Richard Brudnick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
James Brudnick Co., Inc. | |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic services | Health Services |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Health Technology |
